A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically

Chao Ma1, Rong Fan, Habib Ahmad

  • 1NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, California, USA.

Nature Medicine
|May 24, 2011
PubMed

Insights

This study introduces a microfluidic platform for analyzing single-cell immune responses. It reveals significant functional diversity in tumor-specific T cells, aiding immune monitoring.

Area of Science:

  • Immunology
  • Biotechnology
  • Microfluidics

Background:

  • Cellular immunity exhibits high functional heterogeneity.
  • Analyzing diverse effector molecules from single cells is crucial for understanding immune responses.
  • Existing methods may lack the multiplexing or efficiency needed for comprehensive analysis.

Purpose of the Study:

  • To develop and validate a microfluidic platform for highly multiplexed, quantitative single-cell protein analysis.
  • To assess the functional heterogeneity of tumor antigen-specific cytotoxic T lymphocytes (CTLs).
  • To compare the platform's performance against standard immunotechnologies.

Main Methods:

  • A novel microfluidic platform enabling measurement of >10 secreted proteins per cell.
  • Validation using lipopolysaccharide (LPS)-stimulated human macrophages and cytokine analysis.
  • Ex vivo analysis of T cell polyfunctional diversity in tumor patients versus healthy donors.

Main Results:

  • The platform reliably quantifies multiple secreted proteins from single cells with high sample efficiency.
  • Profound, yet focused, functional heterogeneity was observed in tumor antigen-specific CTLs.
  • Major functional phenotypes of responding T cells were quantitatively identified.

Conclusions:

  • The developed microfluidic platform is an informative tool for immune monitoring.
  • It enables quantitative assessment of T cell polyfunctional diversity.
  • This technology can advance clinical assessment and understanding of immune responses.